[Skip to Content]
[Skip to Content Landing]
Views 308
Citations 0
Comment & Response
February 2017

Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy

Author Affiliations
  • 1Department of General Internal Medicine, Kameda Medical Center, Kamogawa City, Chiba, Japan
  • 2Department of Primary Care and Medical Education, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba City, Ibaraki, Japan
  • 3Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Tsukuba City, Ibaraki, Japan
JAMA Intern Med. 2017;177(2):284. doi:10.1001/jamainternmed.2016.8577

To the Editor In their Original Investigation in a recent issue of JAMA Internal Medicine, Dr Uranga and colleagues1 reported that patient outcomes were not significantly different when antibiotic treatment was discontinued based on clinical stability criteria after a minimum of 5 days of appropriate treatment compared with standard treatment length as determined by physicians. They concluded that the shorter course of treatment was not inferior and that the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) guidelines regarding the duration of antibiotic treatment can be safely implemented among hospitalized patients with community-acquired pneumonia.1

×